How many clinical trials are studying CC312?

3 recruiting trials in our tracked data involve CC312.

What conditions is CC312 being studied for?

In our tracked recruiting trials, CC312 is being studied in trials for Lupus, SLE - Systemic Lupus Erythematosus, Autoimmune Hemolytic Anemia.

Recruiting trials

Conditions studied

US states with sites

Countries

Early Phase 1 2 Phase 1 1

Condition	Trials
Lupus · CC312 for Lupus	3
SLE - Systemic Lupus Erythematosus	2
Autoimmune Hemolytic Anemia	1
IIM- Idiopathic Inflammatory Myopathies	1
Idiopathic Inflammatory Myopathy (IIM)	1
Primary Immune Thrombocytopenia (ITP)	1
Rheumatoid Arthritis (RA)	1
Rheumatoid arthritis	1
SSc-Systemic Sclerosis	1
Systemic Lupus Erythematosus (SLE)	1
Systemic Sclerosis (SSc)	1

A Study of CC312 for Relapsed/Refractory Autoimmune Diseases
NCT07193810 · Phase: Early Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
Safety Study of CC312 in Autoimmune Disease Patients
NCT06888960 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
Safety and Efficacy Study of CC312 for Moderate to Severe SLE
NCT07177911 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location